Putnam Investments’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $3.62M | Sell |
45,486
-74,780
| -62% | -$5.95M | ﹤0.01% | 532 |
|
|
2023
Q3 | $8.41M | Buy |
120,266
+2,959
| +3% | +$207K | 0.01% | 333 |
|
|
2023
Q2 | $8.43M | Buy |
117,307
+2,487
| +2% | +$179K | 0.01% | 347 |
|
|
2023
Q1 | $7.08M | Buy |
114,820
+581
| +0.5% | +$35.8K | 0.01% | 380 |
|
|
2022
Q4 | $8.81M | Buy |
114,239
+1,667
| +1% | +$129K | 0.02% | 311 |
|
|
2022
Q3 | $5.02M | Buy |
+112,572
| New | +$5.02M | 0.01% | 432 |
|